The DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index.
Dendrimers in drug delivery and targeting: Drug-dendrimer interactions and toxicity issues
Open accessAbstract
Dendrimers are the emerging polymeric architectures that are known for their defined structures, versatility in drug delivery and high functionality whose properties resemble with biomolecules. These nanostructured macromolecules have shown their potential abilities in entrapping and/or conjugating the high molecular weight hydrophilic/hydrophobic entities by host-guest interactions and covalent bonding (prodrug approach) respectively. Moreover, high ratio of surface groups to molecular volume has made them a promising synthetic vector for gene delivery. Owing to these properties dendrimers have fascinated the researchers in the development of new drug carriers and they have been implicated in many therapeutic and biomedical applications. Despite of their extensive applications, their use in biological systems is limited due to toxicity issues associated with them. Considering this, the present review has focused on the different strategies of their synthesis, drug delivery and targeting, gene delivery and other biomedical applications, interactions involved in formation of drug-dendrimer complex along with characterization techniques employed for their evaluation, toxicity problems and associated approaches to alleviate their inherent toxicity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Drug Delivery Systems: Entering the Mainstream
Allen, T. M., & Cullis, P. R. (2004) · Science · doi:10.1126/science.1095833 · Cited by 4,552 · cited 1×
“[23] Unlike traditional polymers, dendrimers have received considerable attention in biological applications due to their high water solubility, [24] biocompatibility, [25] polyvalency [12] and precise molecular weight.”
A New Class of Polymers: Starburst-Dendritic Macromolecules
Tomalia, D. A., Baker, H., Dewald, J., Hall, M., Kallos, G., Martin, S., Roeck, J., Ryder, J., & Smith, P. (1985) · Polymer Journal · doi:10.1295/polymj.17.117 · Cited by 3,904
Hawker, C. J., & Frechet, J. M. J. (1990) · Journal of the American Chemical Society · doi:10.1021/ja00177a027 · Cited by 2,413
Nanoparticle and targeted systems for cancer therapy
Brannon-Peppas, L., & Blanchette, J. O. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.02.014 · Cited by 2,334
Fischer, D., Li, Y., Ahlemeyer, B., Krieglstein, J., & Kissel, T. (2003) · Biomaterials · doi:10.1016/s0142-9612(02)00445-3 · Cited by 2,329
Dendrimers in biomedical applications—reflections on the field
SVENSON, S., & TOMALIA, D. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.09.018 · Cited by 1,919
Encapsulation of Guest Molecules into a Dendritic Box
Jansen, J. F. G. A., de Brabander-van den Berg, E. M. M., & Meijer, E. W. (1994) · Science · doi:10.1126/science.266.5188.1226 · Cited by 1,167
Dendrimer biocompatibility and toxicity
DUNCAN, R., & IZZO, L. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.09.019 · Cited by 1,158
Dendrimer as nanocarrier for drug delivery
Kesharwani, P., Jain, K., & Jain, N. K. (2014) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2013.07.005 · Cited by 1,146
Tomalia, D. A. (2005) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2005.01.007 · Cited by 1,115
DUFES, C., UCHEGBU, I., & SCHATZLEIN, A. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.09.017 · Cited by 984
Discovery of dendrimers and dendritic polymers: A brief historical perspective*
Tomalia, D. A., & Fréchet, J. M. J. (2002) · Journal of Polymer Science Part A: Polymer Chemistry · doi:10.1002/pola.10301 · Cited by 908
The influence of surface modification on the cytotoxicity of PAMAM dendrimers
Jevprasesphant, R. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00623-3 · Cited by 726
Dendrimer‐based metal chelates: A new class of magnetic resonance imaging contrast agents
Wiener, E., Brechbiel, M. W., Brothers, H., Magin, R. L., Gansow, O. A., Tomalia, D. A., & Lauterbur, P. C. (1994) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910310102 · Cited by 718
Dendrimer toxicity: Let's meet the challenge
Jain, K., Kesharwani, P., Gupta, U., & Jain, N. K. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.04.027 · Cited by 710
Biomedical applications of dendrimers: a tutorial
Mintzer, M. A., & Grinstaff, M. W. (2011) · Chem. Soc. Rev. · doi:10.1039/b901839p · Cited by 671
Lee, C. C., Gillies, E. R., Fox, M. E., Guillaudeu, S. J., Fréchet, J. M. J., Dy, E. E., & Szoka, F. C. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607705103 · Cited by 650
Northfelt, D. W., Dezube, B. J., Thommes, J. A., Miller, B. J., Fischl, M. A., Friedman-Kien, A., Kaplan, L. D., Du Mond, C., Mamelok, R. D., & Henry, D. H. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.7.2445 · Cited by 649
PATRI, A., KUKOWSKALATALLO, J., & BAKERJR, J. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.09.014 · Cited by 597
Preliminary biological evaluation of polyamidoamine (PAMAM) StarburstTM dendrimers
Roberts, J. C., Bhalgat, M. K., & Zera, R. T. (1996) · Journal of Biomedical Materials Research · doi:10.1002/(sici)1097-4636(199601)30:1<53::aid-jbm8>3.0.co;2-q · Cited by 589
DEMANUELE, A., & ATTWOOD, D. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.09.012 · Cited by 571
Nanoparticle-assisted Combination Therapies for Effective Cancer Treatment
Hu, C.-M. J., Aryal, S., & Zhang, L. (2010) · Therapeutic Delivery · doi:10.4155/tde.10.13 · Cited by 564
Dendrimers: Emerging polymers for drug-delivery systems
Nanjwade, B. K., Bechra, H. M., Derkar, G. K., Manvi, F. V., & Nanjwade, V. K. (2009) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2009.07.008 · Cited by 542
Therapeutic and diagnostic applications of dendrimers for cancer treatment☆
WOLINSKY, J., & GRINSTAFF, M. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.02.012 · Cited by 540
Biological applications of dendrimers
Cloninger, M. J. (2002) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(02)00400-3 · Cited by 516
Dendrimer-platinate: a novel approach to cancer chemotherapy.
Malik, N., Evagorou, E. G., & Duncan, R. (1999) · PubMed · Cited by 417
Drug complexation, in vitro release and cellular entry of dendrimers and hyperbranched polymers
Kolhe, P. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(03)00225-4 · Cited by 412
Chen, H.-T., Neerman, M. F., Parrish, A. R., & Simanek, E. E. (2004) · Journal of the American Chemical Society · doi:10.1021/ja048548j · Cited by 411
Vandamme, T. F., & Brobeck, L. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.09.015 · Cited by 401
Dendrimer-mediated transdermal delivery: enhanced bioavailability of indomethacin
Chauhan, A. S., Sridevi, S., Chalasani, K. B., Jain, A. K., Jain, S. K., Jain, N. K., & Diwan, P. V. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00200-1 · Cited by 344
ChemInform Abstract: ′CASCADE′‐ AND ′NONSKID‐CHAIN‐LIKE′ SYNTHESES OF MOLECULAR CAVITY TOPOLOGIES
BUHLEIER, E., WEHNER, W., & VOEGTLE, F. (1978) · Chemischer Informationsdienst · doi:10.1002/chin.197825228 · Cited by 320
Wang, F., Bronich, T. K., Kabanov, A. V., Rauh, R. D., & Roovers, J. (2005) · Bioconjugate Chemistry · doi:10.1021/bc049784m · Cited by 317 · cited 1×
“…delivery [42] Furosemide Diuretic G4 PAMAM Increased solubility and sustained release [43] Etoposide Anticancer PAMAM High loading capacity [44] Erythromycin Bactericidal antibiotic G4 PAMAM Sustained release and improved activity [45] Zidovudine Anti‑HIV G4 PPI Targeted delivery [46]…”
Morgan, M. T., Nakanishi, Y., Kroll, D. J., Griset, A. P., Carnahan, M. A., Wathier, M., Oberlies, N. H., Manikumar, G., Wani, M. C., & Grinstaff, M. W. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-2066 · Cited by 301
Characterization of dendrimers
CAMINADE, A., LAURENT, R., & MAJORAL, J. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.09.011 · Cited by 297
Lipid Bilayer Disruption by Polycationic Polymers: The Roles of Size and Chemical Functional Group
Mecke, A., Majoros, I. J., Patri, A. K., Baker, J. R., Banaszak Holl, M. M., & Orr, B. G. (2005) · Langmuir · doi:10.1021/la050629l · Cited by 283
D'Emanuele, A., Jevprasesphant, R., Penny, J., & Attwood, D. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2003.12.006 · Cited by 269
New Basic Membrane-Destabilizing Peptides for Plasmid-Based Gene Delivery in Vitro and in Vivo
Rittner, K., Benavente, A., Bompard-Sorlet, A., Heitz, F., Divita, G., Brasseur, R., & Jacobs, E. (2002) · Molecular Therapy · doi:10.1006/mthe.2002.0523 · Cited by 257
Dendritic Molecular Capsules for Hydrophobic Compounds
Morgan, M. T., Carnahan, M. A., Immoos, C. E., Ribeiro, A. A., Finkelstein, S., Lee, S. J., & Grinstaff, M. W. (2003) · Journal of the American Chemical Society · doi:10.1021/ja0347383 · Cited by 252
Patri, A. K., Myc, A., Beals, J., Thomas, T. P., Bander, N. H., & Baker, J. R. (2004) · Bioconjugate Chemistry · doi:10.1021/bc0499127 · Cited by 249
Gene delivery using dendrimer-entrapped gold nanoparticles as nonviral vectors
Shan, Y., Luo, T., Peng, C., Sheng, R., Cao, A., Cao, X., Shen, M., Guo, R., Tomás, H., & Shi, X. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2011.12.045 · Cited by 242
Liu, H., Wang, H., Yang, W., & Cheng, Y. (2012) · Journal of the American Chemical Society · doi:10.1021/ja307290j · Cited by 236
Beezer, A. E., King, A. S. H., Martin, I. K., Mitchel, J. C., Twyman, L. J., & Wain, C. F. (2003) · Tetrahedron · doi:10.1016/s0040-4020(03)00437-x · Cited by 230
Khandare, J. J., Jayant, S., Singh, A., Chandna, P., Wang, Y., Vorsa, N., & Minko, T. (2006) · Bioconjugate Chemistry · doi:10.1021/bc060240p · Cited by 226
Yiyun, C., Na, M., Tongwen, X., Rongqiang, F., Xueyuan, W., Xiaomin, W., & Longping, W. (2007) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20745 · Cited by 225
Intracellular macrophage uptake of rifampicin loaded mannosylated dendrimers
Kumar, P. V., Asthana, A., Dutta, T., & Jain, N. K. (2006) · Journal of Drug Targeting · doi:10.1080/10611860600825159 · Cited by 215
Bioinspired application of dendrimers: From bio-mimicry to biomedical applications
Jang, W.-D., Kamruzzaman Selim, K. M., Lee, C.-H., & Kang, I.-K. (2009) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2008.08.003 · Cited by 209
Bourne, N., Stanberry, L. R., Kern, E. R., Holan, G., Matthews, B. R., & Bernstein, D. I. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.9.2471-2474.2000 · Cited by 204
Dutta, T., & Jain, N. K. (2007) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2006.12.007 · Cited by 200
In vitro evaluation of dendrimer prodrugs for oral drug delivery
Najlah, M., Freeman, S., Attwood, D., & D’Emanuele, A. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.11.047 · Cited by 195
Ma, M., Cheng, Y., Xu, Z., Xu, P., Qu, H., Fang, Y., Xu, T., & Wen, L. (2007) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2006.07.015 · Cited by 190
Santos, J. L., Oliveira, H., Pandita, D., Rodrigues, J., Pêgo, A. P., Granja, P. L., & Tomás, H. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.01.034 · Cited by 189
Self-citationWang, Y., Guo, R., Cao, X., Shen, M., & Shi, X. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2010.12.060 · Cited by 189
Endocytosis and Interaction of Poly (Amidoamine) Dendrimers with Caco-2 Cells
Kitchens, K. M., Foraker, A. B., Kolhatkar, R. B., Swaan, P. W., & Ghandehari, H. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9415-0 · Cited by 182
Dendrimers conjugates for colonic delivery of 5-aminosalicylic acid
Wiwattanapatapee, R., Lomlim, L., & Saramunee, K. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00461-3 · Cited by 178
Wu, G., Barth, R. F., Yang, W., Kawabata, S., Zhang, L., & Green-Church, K. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0325 · Cited by 177
Transepithelial and endothelial transport of poly (amidoamine) dendrimers
KITCHENS, K., ELSAYED, M., & GHANDEHARI, H. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.09.013 · Cited by 177
Kaminskas, L. M., McLeod, V. M., Kelly, B. D., Sberna, G., Boyd, B. J., Williamson, M., Owen, D. J., & Porter, C. J. H. (2012) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2011.05.013 · Cited by 176
Activity of Dendrimer−Methotrexate Conjugates on Methotrexate-Sensitive and -Resistant Cell Lines
Gurdag, S., Khandare, J., Stapels, S., Matherly, L. H., & Kannan, R. M. (2006) · Bioconjugate Chemistry · doi:10.1021/bc0501855 · Cited by 165
Devarakonda, B., Hill, R. A., Liebenberg, W., Brits, M., & de Villiers, M. M. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.07.023 · Cited by 162
Influence of PAMAM dendrimers on human red blood cells
Domański, D. M., Klajnert‐Maculewicz, B., & Bryszewska, M. J. (2004) · Bioelectrochemistry · doi:10.1016/j.bioelechem.2003.09.023 · Cited by 160
Santos, J. L., Pandita, D., Rodrigues, J., Pêgo, A. P., Granja, P. L., & Tomás, H. (2011) · Current Gene Therapy · doi:10.2174/156652311794520102 · Cited by 156
Self-citationDelivery of paclitaxel across cellular barriers using a dendrimer-based nanocarrier
Teow, H. M., Zhou, Z., Najlah, M., Yusof, S. R., Abbott, N. J., & D’Emanuele, A. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.10.024 · Cited by 155
Penicillin V-conjugated PEG-PAMAM star polymers
Yang, H., & Lopina, S. T. (2003) · Journal of Biomaterials Science Polymer Edition · doi:10.1163/156856203769231556 · Cited by 148
Devarakonda, B., Otto, D. P., Judefeind, A., HILL, R., & DeVilliers, M. M. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.05.039 · Cited by 146
Polyamidoamine dendrimer hydrogel for enhanced delivery of antiglaucoma drugs
Holden, C. A., Tyagi, P., Thakur, A., Kadam, R. S., Jadhav, G., Kompella, U. B., & Yang, H. (2011) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2011.08.018 · Cited by 143
Dutta, T., Garg, M., & Jain, N. K. (2008) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2008.04.002 · Cited by 140
Ooya, T., Lee, J., & Park, K. (2004) · Bioconjugate Chemistry · doi:10.1021/bc049814l · Cited by 140
Cationic PAMAM Dendrimers Disrupt Key Platelet Functions
Jones, C. F., Campbell, R. A., Franks, Z. G., Gibson, C. C., Thiagarajan, G., Vieira‐de‐Abreu, A., Sukavaneshvar, S., Mohammad, S., Li, D. Y., Ghandehari, H., et al. (2012) · Molecular Pharmaceutics · doi:10.1021/mp2006054 · Cited by 138
Papagiannaros, A., Dimas, K., Papaioannou, G. T., & Demetzos, C. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.05.039 · Cited by 117
Dendrimer-Based Targeted Delivery of an Apoptotic Sensor in Cancer Cells
Myc, A., Majoros, I., Thomas, T. P., & Baker, J. R. (2006) · Biomacromolecules · doi:10.1021/bm060815l · Cited by 114
Santos, J. L., Pandita, D., Rodrigues, J., Pêgo, A. P., Granja, P. L., Balian, G., & Tomás, H. (2010) · Molecular Pharmaceutics · doi:10.1021/mp9002877 · Cited by 110
Self-citationLigand anchored dendrimers based nanoconstructs for effective targeting to cancer cells
Gupta, U. D., Dwivedi, S. K. D., Bid, H. K., Konwar, R., & Jain, N. K. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.04.002 · Cited by 107
Prajapati, R. N., Tekade, R. K., Gupta, U. D., et al. (2009) · Molecular Pharmaceutics · doi:10.1021/mp8002489 · Cited by 104
Charge affects the oral toxicity of poly(amidoamine) dendrimers
Thiagarajan, G., Greish, K. F., & Ghandehari, H. (2013) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2013.01.019 · Cited by 104
Battah, S., Balaratnam, S., Casas, A. G., O’Neill, S., Edwards, C., Batlle, A. M. D. C., Dobbin, P. S., & MacRobert, A. J. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0359 · Cited by 104
Nanoparticle Albumin–Bound Paclitaxel for Metastatic Breast Cancer
Harries, M., Ellis, P., & Harper, P. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.08.002 · Cited by 100
Dendrimers: Analytical characterization and applications
Biricová, V., & Lázníčková, A. (2009) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2009.07.006 · Cited by 99
Gupta, U. D., Agashe, H. B., & Jain, N. K. (2007) · PubMed · Cited by 93
Arginine modified PAMAM dendrimer for interferon beta gene delivery to malignant glioma
Bai, C. Z., Choi, S., Nam, K., An, S., & Park, J. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.01.057 · Cited by 90
Bosnjakovic, A., Mishra, M. K., Ren, W., Kurtoglu, Y. E., Shi, T., Fan, D., & Kannan, R. M. (2010) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2010.10.008 · Cited by 90
PEG-epirubicin Conjugates with High Drug Loading
Pasut, G., Scaramuzza, S., Schiavon, O., Mendichi, R., & Veronese, F. M. (2005) · Journal of Bioactive and Compatible Polymers · doi:10.1177/0883911505053377 · Cited by 87
Herlambang, S., Kumagai, M., Nomoto, T., Horie, S., Fukushima, S., Oba, M., Miyazaki, K., Morimoto, Y., Nishiyama, N., & Kataoka, K. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.06.019 · Cited by 85
Kobayashi, H., Reijnders, K., English, S. J., Yordanov, A. T., Milenic, D. E., Sowers, A. L., Citrin, D. E., Krishna, M. C., Waldmann, T. A., Mitchell, J. B., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1175 · Cited by 85
A 5-fluorouracil-loaded pH-responsive dendrimer nanocarrier for tumor targeting
Jin, Y., Ren, X., Wang, W., Ke, L., Ning, E., Du, L., & Bradshaw, J. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.08.053 · Cited by 83
HER2 specific delivery of methotrexate by dendrimer conjugated anti-HER2 mAb
Shukla, R., Thomas, T. P., Desai, A. M., Kotlyar, A., Park, S. J., & Baker, J. R. (2008) · Nanotechnology · doi:10.1088/0957-4484/19/29/295102 · Cited by 82
Pandita, D., Santos, J. L., Rodrigues, J., Pêgo, A. P., Granja, P. L., & Tomás, H. (2011) · Biomacromolecules · doi:10.1021/bm1012647 · Cited by 81
Self-citationTargeted biodegradable dendritic MRI contrast agent for enhanced tumor imaging
Ye, M., Qian, Y., Tang, J., Hu, H., Sui, M., & Shen, Y. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.01.034 · Cited by 73
Yang, H., & Lopina, S. T. (2004) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.30220 · Cited by 70
Ethylendiamine core PAMAM dendrimers/siRNA complexes as in vitro silencing agents
Perez, A. P., Romero, E. L., & Morilla, M. J. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.06.035 · Cited by 69
Design of interior-functionalized fully acetylated dendrimers for anticancer drug delivery
Hu, J., Su, Y., Zhang, H., Xu, T., & Cheng, Y. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.09.016 · Cited by 65
Solubility enhancement of paclitaxel using a linear-dendritic block copolymer
Zhou, Z., D’Emanuele, A., & Attwood, D. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.04.075 · Cited by 58
Battah, S., O’Neill, S., Edwards, C., Balaratnam, S., Dobbin, P. S., & MacRobert, A. J. (2006) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2006.02.001 · Cited by 57
Dendrimers and their applications in immunoassays and clinical diagnostics
Singh, P. (2007) · Biotechnology and Applied Biochemistry · doi:10.1042/ba20070019 · Cited by 52
Investigation of a novel dendritic derivative of 5-aminolaevulinic acid for photodynamic therapy
Venosa, G. M. D., Casas, A. G., Battah, S., Dobbin, P. S., Fukuda, H., MacRobert, A. J., & Batlle, A. M. D. C. (2005) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2005.08.001 · Cited by 50
Soto‐Castro, D., Cruz‐Morales, J. A., Apán, M. T. R., & Guadarrama, P. (2012) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2012.01.002 · Cited by 49
Devarakonda, B., Li, N., & de Villiers, M. M. (2005) · AAPS PharmSciTech · doi:10.1208/pt060363 · Cited by 44
Sideratou, Z., Kontoyianni, C., Drossopoulou, G. I., & Paleos, C. M. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.09.058 · Cited by 40
Dutta, T., Garg, M., Dubey, V., Mishra, D. K., Singh, K., Pandita, D., Singh, A. K., Ravi, A. K., Velpandian, T., & Jain, N. K. (2008) · Nanotoxicology · doi:10.1080/17435390802105167 · Cited by 23
Self-citation
Cited by
Nano based drug delivery systems: recent developments and future prospects
Patra, J. K., Das, G., Fraceto, L. F., Campos, E. V. R., Rodriguez-Torres, M. D. P., Acosta-Torres, L. S., Diaz-Torres, L. A., Grillo, R., Swamy, M. K., Sharma, S., et al. (2018) · Journal of Nanobiotechnology · doi:10.1186/s12951-018-0392-8 · Cited by 6,684
Smart nanocarrier-based drug delivery systems for cancer therapy and toxicity studies: A review
Hossen, S., Hossain, M. K., Basher, M. K., Mia, M. N. H., Rahman, M. T., & Uddin, M. J. (2019) · Journal of Advanced Research · doi:10.1016/j.jare.2018.06.005 · Cited by 998
Mesoporous Silica Nanoparticles: A Comprehensive Review on Synthesis and Recent Advances
Narayan, R., Nayak, U. Y., Raichur, A. M., & Garg, S. (2018) · Pharmaceutics · doi:10.3390/pharmaceutics10030118 · Cited by 942
Dendrimers as Nanocarriers for Nucleic Acid and Drug Delivery in Cancer Therapy
Palmerston Mendes, L., Pan, J., & Torchilin, V. (2017) · Molecules · doi:10.3390/molecules22091401 · Cited by 701
Tapeinos, C., Battaglini, M., & Ciofani, G. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.08.033 · Cited by 539
Metadata
- Authors
- Pandita, D., Madaan, K., Kumar, S., Poonia, N., & Lather, V.
- Venue
- Journal of Pharmacy And Bioallied Sciences
- Publisher
- Medknow
- Published
- 2014
- Volume
- 6
- Issue
- 3
- Pages
- 139
- ISSN
- 0975-7406 (ISSN-L)
- OpenAlex
- W1994936258
- Cited by
- 679
- References
- 98
- FWCI
- 18.64
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.